Eikon Therapeutics

Edit info

Founded: 2019

Location: Hayward, CA

Employee range: 11 - 50

Clinical stage: RD

Therapy area: Undisclosed

Drug types: ONC

Lead product: Undisclosed

Funding: $106M C Jun 2023; $518M B Jan 2022; $148M A May 2021

eikontx.com

linkedin.com

job board

Business:

Single Particle Tracking

Drug notes:

EIK1003 Clin1 Solid tumors; 2 Undisclosed Clin0 oncology; 7 undisclosed RD oncology

About:

Eikon Therapeutics is using super-resolution microscopy for drug development. Advances in super-resolution fluorescence microscopy has now made it possible to follow the dynamics of individual proteins in living cells. Measurements from single particle tracking enable the calculation of protein angular movements, on-rates/off-rates and residence times for binding events. Eikon is using this technology to assess protein dynamics and reveal novel biological mechanisms of action, thus providing new therapeutic approaches. This requires the combination of engineering, computation, biology, medicinal chemistry and pharmacology expertise. Eikon’s pipeline is designed to achieve effective therapeutics for unmet medical needs.

Clinical Trial Manager, Oncology

Millbrae, CA New York, NY Jersey City, NJ|8 days ago